Group 1 - Multiple Hong Kong AI medical concept stocks showed active performance on February 10, with Yunzhisheng rising by 11.64%, Inspur Intelligent by 9.46%, Yidu Tech by 2.94%, and Jingtai Holdings by 2.66% [1] - Yunzhisheng announced on February 9 that it completed the placement of 1.008 million new H-shares, accounting for approximately 2.32% of the total issued H-shares and 1.38% of the total issued shares after the placement [3] - The placement price for each H-share was set at HKD 310, with net proceeds from the placement amounting to approximately HKD 307 million, of which about 65% will be used for core technology research and development [3]